Pancreatic Cancer Q&A with Dr. Stauffer, Mayo Surgeon: May 29
Allow me to introduce you to Dr. John Stauffer, a hepatobiliary and pancreas surgical oncologist at Mayo Clinic in Florida, one of the country's highest-volume surgical programs for advanced pancreatic cancer.
On Thursday, May 29 from 1:30-2:30pm ET, Dr. Stauffer will host a Q&A about surgical management of pancreatic cancer.
After a pancreatic cancer diagnosis, many people have questions about treatment options, including surgical and nonsurgical approaches. You may also want to know how an integrated team – including surgical oncology, medical oncology, radiation oncology and gastroenterology specialists – works together to prevent further cancer complications and preserve your quality of life.
Please note that this hour-long Q&A is for informational purposes only, and any concerns you have should be addressed to your treating physician. If you would like to learn about pancreas cancer care at our integrated program in Florida, please visit this page for information.
Submit your questions in advance in the comments below and Dr. Stauffer will reply during the hour-long Q&A event. See you back here on May 29.
Go ahead, ask away!
Interested in more discussions like this? Go to the Pancreatic Cancer Support Group.
As a PNet surgical success story I send hope to all. The team at Mayo is the best and Dr. Poruk saved my life with her high level of expertise, sprinkled with confident, calm compassion.
Hi everyone, Dr. Stauffer here, I am ready to answer your questions! I will go through the list and comment on questions in the chat over the next hour. Thank you for taking the time to share your questions with us.
I recommend a whipple if the next EMR finds HGD or the margin is still positive due to the risk of malignant degeneration. Duodenal cancer is very survivable if found and treated at this early stage but can lead to uncurable metastatic cancer if undertreated.
In rare circumstances (oligometastatic PDAC), we would consider aggressive treatment of metastatic liver disease after a time period demonstrating disease stability and appropriate tumor biology (6-12 months).
A more aggressive resection (total pancreatectomy, vascular resection, extended lymphadenectomy, etc…) when a standard resection obtains negative margins has not been shown to improve survival. Experienced surgeons and teams carefully plan each operation to maximize the chances of cure without increasing the chances of surgical complications or poor quality of life after surgery.
I assume the next EMR will find HGD as it wasn't previously removed. How long can surgery be put off? I keep getting different opinions
I have found PET to be imperfect when identifying recurrent cancer within the abdomen. There are many cases of nebulous results which can be due to inflammation, infection, or some other cause of hypermetabolism and not due to recurrent cancer. At MCF, we use very high-quality MRI to better detect whether there is recurrent PDAC or not but even then, it is not entirely accurate.
To be fair, I have not thoroughly reviewed these articles and data enough to definitively support or deny if they provide any additional benefits to our standard of care treatment of pancreatic cancer.
Yes, Dr. Poruk is an awesome surgeon and a great colleague!
For statistical purposes, we feel that the 5-year mark with NED is counted as cure. I generally do not recommend doing long term maintenance chemotherapy if someone is cancer free for a prolonged period of time after definitive treatment (surgery) of PDAC.